Bio-Rad Laboratories Inc (BIO)

Net profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Net income (ttm) US$ in thousands -1,844,202 -778,694 -1,325,609 -322,369 -637,323 -153,537 -424,026 -188,960 -3,627,532 -6,034,686 -1,942,424 -101,126 4,245,898 6,658,660 4,045,450 4,097,765 3,806,263 3,520,647 1,947,011 1,579,392
Revenue (ttm) US$ in thousands 2,566,525 2,580,209 2,562,604 2,605,238 2,671,262 2,720,366 2,769,042 2,779,031 2,802,249 2,804,730 2,870,979 2,895,811 2,922,545 2,979,615 2,879,829 2,700,778 2,545,626 2,380,215 2,293,585 2,329,324
Net profit margin -71.86% -30.18% -51.73% -12.37% -23.86% -5.64% -15.31% -6.80% -129.45% -215.16% -67.66% -3.49% 145.28% 223.47% 140.48% 151.73% 149.52% 147.91% 84.89% 67.80%

December 31, 2024 calculation

Net profit margin = Net income (ttm) ÷ Revenue (ttm)
= $-1,844,202K ÷ $2,566,525K
= -71.86%

The net profit margin for Bio-Rad Laboratories Inc has shown a significant fluctuation over the past several quarters. Initially, the net profit margin was very healthy, ranging from 67.80% to 151.73% in the period from March 2020 to March 2022. However, starting from June 2022, the net profit margin turned negative and continued to decline sharply, reaching as low as -71.86% by December 2024.

This negative trend in the net profit margin indicates that the company's expenses and costs exceeded its revenue generation during these quarters. Such a decline in profitability could be attributed to various factors such as increased operating expenses, lower sales volumes, or pricing pressures in the market.

It is essential for Bio-Rad Laboratories Inc to closely monitor and address the underlying issues that are impacting its profitability to improve its financial performance and ensure long-term sustainability.